Inventor
WEISKOPF KIPP ANDREW
US25 patents
Patents
25 patentsUS10081680B2Sep 25, 2018
Anti-SIRP-alpha antibodies and bispecific macrophage enhancing antibodies
UNIV LELAND STANFORD JUNIOR42 citations97
US9944911B2Apr 17, 2018
High affinity Sirp-alpha reagents and methods of using
UNIV LELAND STANFORD JUNIOR23 citations93
US10406179B2Sep 10, 2019
Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
UNIV LELAND STANFORD JUNIOR16 citations92
US9771428B2Sep 26, 2017
CD47 targeted therapies for the treatment of infectious disease
UNIV LELAND STANFORD JUNIOR11 citations91
US10781256B2Sep 22, 2020
Anti SIRP-α antibodies and bi-specific macrophage enhancing antibodies
UNIV LELAND STANFORD JUNIOR14 citations85
US10316094B2Jun 11, 2019
Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance
UNIV LELAND STANFORD JUNIOR9 citations84
US9945870B2Apr 17, 2018
Methods for determining responsiveness to an anti-CD47 agent
UNIV LELAND STANFORD JUNIOR9 citations84
US11208481B2Dec 28, 2021
High affinity SIRP-alpha reagents and methods of using
UNIV LELAND STANFORD JUNIOR7 citations83
US10894831B2Jan 19, 2021
Enhanced depletion of targeted cells with CD47 blockade and an immune costimulatory agonist
UNIV LELAND STANFORD JUNIOR8 citations82
US10723803B2Jul 28, 2020
CD47 targeted therapies for the treatment of infectious disease
UNIV LELAND STANFORD JUNIOR8 citations82
US10184004B2Jan 22, 2019
CD47 targeted therapies for the treatment of infectious disease
UNIV LELAND STANFORD JUNIOR7 citations82
US10064925B2Sep 4, 2018
Use of anti-CD47 agents to enhance immunization
UNIV LELAND STANFORD JUNIOR7 citations82
US11608377B2Mar 21, 2023
Enhanced depletion of targeted cells with CD47 blockade and an immune costimulatory agonist
UNIV LELAND STANFORD JUNIOR7 citations81
US12195532B2Jan 14, 2025
High affinity SIRP-alpha reagents and methods of using
UNIV LELAND STANFORD JUNIOR1 citations74
US10889649B2Jan 12, 2021
Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance
UNIV LELAND STANFORD JUNIOR2 citations73
US12030944B2Jul 9, 2024
Enhanced depletion of targeted cells with CD47 blockade and an immune costimulatory agonist
UNIV LELAND STANFORD JUNIOR1 citations71
US11780931B2Oct 10, 2023
CD47 targeted therapies for the treatment of infectious disease
UNIV LELAND STANFORD JUNIOR1 citations71
US11419897B2Aug 23, 2022
Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
UNIV LELAND STANFORD JUNIOR2 citations71
US11230607B2Jan 25, 2022
CD47 targeted therapies for the treatment of infectious disease
UNIV LELAND STANFORD JUNIOR2 citations71
US11459388B2Oct 4, 2022
Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance
UNIV LELAND STANFORD JUNIOR0 citations62
US12410259B2Sep 9, 2025
CD47 targeted therapies for the treatment of infectious disease
UNIV LELAND STANFORD JUNIOR0 citations61
US12233093B2Feb 25, 2025
Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
UNIV LELAND STANFORD JUNIOR0 citations61
US11154600B2Oct 26, 2021
Use of anti-CD47 agents to enhance immunization
UNIV LELAND STANFORD JUNIOR0 citations60
US11046763B2Jun 29, 2021
Targeted therapy for small cell lung cancer
UNIV LELAND STANFORD JUNIOR1 citations56
US10358472B2Jul 23, 2019
High affinity CD47 analogs
UNIV LELAND STANFORD JUNIOR0 citations51